Kenneth Frazier Quotes
I do worry that as we try to fix this long-term debt and deficit situation that we don't destroy the market incentives for biomedical research. What I fear is the government using its considerable clout to say, 'Here's the price we're setting for your medicines.'
Frazier, Kenneth. "Merck CEO Warns on Price Controls." Bloomberg News, 12 Mar. 2013.
In order to obtain the support for Obamacare from the Pharmaceutical industry, Obama, agreed to take this power away from the government.
To the modern reader utterances such as this from a Conservative Prime Minister seem astounding. However, the Great Depression existed in Canada as well as the United States, and Franklin Delano Roosevelt was not the only world leader who would reach the conclusion that business and capitalism must be profoundly regulated and the system changed if it was to be saved.
The major killer diseases such as malaria and sleeping sickness are not contracted by Americans, and America is the only large country in the world where the Governments allow the drug companies to charge such high prices and make such huge profits. So any drug that Americans might pay for is a better potential profit generator than one that would be critical to the lives of millions where the governments to preserve lives would force the prices down or allow other companies to also make the drug. See {628648} for other factors affecting drug company priorities.
The “inflated prices” refers to the fact Americans pay more for pharmaceuticals than any other country in the world as the American government allows the companies to charge any amounts while other governments either negotiate or mandate much lower prices.
Kenneth Carleton Frazier is an American business executive. He is the chairman and CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America). After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first African American man to lead a major pharmaceutical company (part of the Fortune 500 companies). He was elected to the American Philosophical Society in 2018.